Media Coverage header image

Media Coverage

Advanced Search
  • 07112022
    Healthcare IT Today

    The following is a guest article by Tom Romeo, General Manager of Healthcare IT at Quest Diagnostics. With a consistent approach, healthcare professionals can increase efficiency, timeliness and legibility, and better consistency and completeness of patient documentation. Ultimately, these benefits can also improve patient care and quality of service. Specifically, Intelligent Data Capture (IDC) is a tool that can help save time and money – and therefore improve care – by innovatively processing, classifying, extracting, validating and routing materials.

  • 07072022
    360Dx

    Quest Diagnostics said Thursday that it is participating in the CDC's Increasing Community Access to Testing (ICATT) for COVID-19 program. Through the program, Quest will provide $0 out-of-pocket COVID-19 testing to qualifying uninsured individuals at roughly 1,200 of the company's 2,100 patient service centers.

  • 06302022
    Becker's Hospital Review

    As healthcare workers continue to leave the industry at startling rates, health systems must find more effective ways to attract and retain employees. In a June Becker's Hospital Review webinar sponsored by Quest Diagnostics, three healthcare executives discussed current workforce challenges, creative attraction and retention strategies and the results that have been achieved. And how intentional initiatives that focus on helping employees feel like they belong, have a career advancement path, and focus on wellness have also been proven to be effective.

  • 06272022
    Healio

    Following updated hepatitis C virus screening recommendations issued in 2020, HCV screening in pregnancy accelerated across the country, according to a retrospective cohort study published in Obstetrics & Gynecology. “We wanted to see whether or not the revised guidelines — which came out during the COVID-19 pandemic — had an impact in changing physician [HCV screening] ordering patterns,” Harvey W. Kaufman, MD, MBA, FCAP, a senior medical director at Quest Diagnostics in Secaucus, New Jersey, told Healio.

  • 06222022
    Yahoo! News

    Quest Diagnostics has been recognized by the American Heart Association to receive their 2022 Award for Meritorious Achievement for our commitment to health care equity. Quest is removing barriers to health care for people in under-served communities and encouraging diversity in health care professionals through sponsorship of the AHA’s Historically Black Colleges and Universities Scholars Program and the Hispanic Serving Institutions Scholars Program.

  • 06202022
    HealthDay

    There has been substantial progress in the proportion of pregnant persons screened for hepatitis C virus, but the testing rates are still low, according to an article published in Obstetrics & Gynecology. Harvey W. Kaufman, M.D., from Quest Diagnostics in Secaucus, New Jersey, and colleagues examined the effect of the 2020 U.S. Centers for Disease Control and Prevention and U.S. Preventive Services Task Force recommendations on HCV screening among pregnant persons.

  • 06162022
    Inside Precision Medicine

    While there have been opportunities to apply digital pathology technologies for some time for secondary consultations, training and educational settings, and to review cases involving specialty stains, the ability to use digital pathology for a primary read is fairly new,” noted Kristie Dolan, vice president and general manager of oncology at Quest Diagnostics.

  • 06132022
    Lab Pulse

    A joint study conducted by Quest Diagnostics and the U.S. Centers for Disease Control and Prevention (CDC) has found that while the rate of hepatitis C (HCV) antibody screening increased 145% in pregnant people during the decade-long study period ending in June 2021, less than half of all pregnant people were screened in early 2021.

  • 06082022
    MedCity News

    In 2020, Covid-19 prompted a delay of non-urgent in-person medical care and concurrently exacerbated contributors to substance use disorders, including job loss, economic hardship and mental health issues. A Health Trends report from Quest Diagnostics found that 70% of physicians fear they missed signs of drug misuse during the pandemic, and the large majority fear overdose deaths will continue to rise even as the pandemic subsides.

  • 06062022
    Choose Healthy Life

    Governor Kathy Hochul today recognized Choose Healthy Life for its work during the pandemic for offering COVID-19 testing and vaccinations through its Black churches across the five boroughs of New York. The state’s commitment is part of a public-private collaboration that includes funding support from founding CHL partner Quest Diagnostics Foundation to hire the church-based community health workforce that has been established in New York and engaging the underserved communities in preventive care and wellness.

  • 06022022
    Yahoo! News

    Quest for Health Equity (Q4HE) and several Quest employees participated in an Earth Day weekend community event with the Black Church Food Security Network; an association of congregations, farmers, food advocates, and community activists working together to create an alternative food system in the Baltimore metropolitan area.

  • 06012022
    Clinical Lab Manager

    Before the COVID-19 pandemic, at Quest Diagnostics, we were in the midst of challenging what a traditional lab looked like to enhance quality, capacity, and efficiency while improving the employee experience. We remained committed to moving our East Region lab operations from our legacy lab in Teterboro, NJ, to Clifton, NJ, despite the pandemic challenges. The Clifton lab was built for our employees, with our employees.

  • 05272022
    360Dx

    As drugs to treat Alzheimer's disease come to market, led by the US Food and Drug Administration approval of Biogen's Aduhelm nearly a year ago, diagnostic tests to detect the disease are following suit. Blood-based biomarker tests have gained particular prominence, as they're less invasive and cheaper than both PET imaging and cerebrospinal fluid (CSF) biomarker testing – two current standards of care for patients presenting with Alzheimer's symptoms. Michael Racke, medical director for neurology at Quest Diagnostics, said in an interview that plasma tests are beneficial because they can be used to screen patients who are "normal cognitively" and may be candidates for intervention before they decline.

  • 05262022
    Health

    "Allergy and Omicron symptoms may mimic one another," Jeffrey Dlott, MD, senior medical director at Quest Diagnostics, told Health. "Because of this, someone may confuse COVID symptoms for allergy symptoms and not take the proper precautions to reduce spread." Here's what to know about how similar Omicron symptoms can look compared to allergies, and steps to take to confirm either diagnosis.

  • 05262022
    Clinical Lab Products

    Liquid biopsy is proving itself as both an efficacious and cost-effective way to provide a cancer diagnosis to patients. However, to fully realize its potential there will need to be a paradigm shift with a focus on primary care physicians and collaboration across the healthcare enterprise. By Yuri Fesko, MD

  • 05232022
    Eat This, Not That!

    Springtime can be a beautiful time of year. Flowers are blooming, trees are budding, and vibrant colors are simply popping out all over. If you deal with seasonal allergies, though, the side effects aren't too pretty. We spoke with Dr. Jeffrey Dlott, Medical Director, QuestDirect to get the lowdown on the ugly side effects of seasonal allergies.

  • 05172022
    American Journal of Managed Care

    By predicting which individuals are most likely to require therapies for chronic kidney disease within the next year, health plans can better organize resource allocation to smooth or delay the transition for the patient, according to Rehan Waheed, MD of Quest Diagnostics.

  • 05172022
    EHS Today

    The rate of positive drug test results among America’s workforce in 2021 reached its highest level since 2001 and was up more than 30% in the combined workforce from an all-time low in 2010-2012, Quest Diagnostics’ annual Drug Testing Index found. Although year-over-year comparisons showed only small increases in 2021 over 2020, Quest said it rose substantially over the previous five years in most drug categories.

  • 05132022
    NeurologyLive

    A Harris Poll conducted by Quest Diagnostics suggests that more than 65% of US physicians believe the Alzheimer disease field is on the cusp of a breakthrough, with more than 80% noting that earlier evaluation with blood testing may help improve therapeutic approaches.

  • 05122022
    Healthcare Business Today

    "2022 Health at Work" report from Quest Diagnostics reveals the attitudes and expectations of HR executive decision makers (HREs) and employees about the changing world of work, employee health and COVID-19, and what it takes to compete for today's scarcest resource–people.

  • 05112022
    Becker's Hospital Review

    A majority of physicians believe medicine is on the verge of groundbreaking new treatments for Alzheimer's disease, according to research from Quest Diagnostics.

  • 05112022
    360Dx

    While value-based care contracts have long played a role in the lab industry, recent comments by Quest Diagnostics executives suggest that such arrangements are growing more prominent and more profitable.

  • 05102022
    BenefitsPRO Magazine

    As millions of U.S. employees voluntarily resign and employers desperately scramble to find workers, a new survey suggests employee health strategy might be critical not only to keeping employees well but also keeping them at work. The “2022 Health at Work” report, released by Quest Diagnostics, addresses such hot-button topics as the changing world of work, employee health, and COVID-19.

  • 05092022
    The Pathologist

    Digital pathology is here to stay – and we need to embrace it. About the Author: Martin Potash is Managing Director of AmeriPath Denver, Quest Diagnostics, Colorado, USA.

  • 05042022
    MedCity News

    Testing giant Quest Diagnostics is diving into the market for blood tests that aid in the early detection of Alzheimer’s disease. The disease afflicts millions of people around the world. But early detection typically relies on costly methods such as brain imaging and cerebrospinal fluid taps. Blood tests like the one developed by Quest promise to make detection easier, less costly and more accessible.

Show 5102550100 per page